InsiderTrades

Form 4 for EYPT EyePoint, Inc.

Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0002013623-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-01-07 2026-01-05 EYPT Ribeiro Ramiro Chief Medical Off M - OptEx $8.26 +29.2K 42.5K +220% +$241.6K
DT 2026-01-07 2026-01-05 EYPT Ribeiro Ramiro Chief Medical Off S - Sale+OE $17.10 -42.5K 0 -100% -$727.5K
DT 2026-01-07 2026-01-05 EYPT Ribeiro Ramiro Chief Medical Off M - OptEx $0.00 -29.2K 87.8K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-05 M A 29,250 $8.26 42,544 D — —
2 Common Common Stock 2026-01-05 S D 42,544 $17.10 0 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 to $17.51. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2026-01-05 M D 29,250 $0.00 87,750 D $8.26 · — to 2035-01-03 29,250 Common Stock (F2) The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.